Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Assertio Therapeutics Inc (ASRT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Assertio Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.0350 -0.0200    -1.90%
18:03:59 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 246,522
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 1.0200 - 1.0600
Type:  Equity
Market:  United States
Assertio Therapeutics 1.0350 -0.0200 -1.90%

ASRT Balance Sheet

 
Assess the latest Depomed balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced ASRT Annual Report data, financial summaries and charts are available for Assertio Therapeutics Inc investors with their own InvestingPro account.
AnnualQuarterly
Advanced Balance Sheet
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Current Assets 172.47 171.06 184.96 133.55
Cash and Short Term Investments 80.74 73.44 76.89 70.18
Cash - - - -
Cash & Equivalents 80.74 73.44 76.89 70.18
Short Term Investments - - - -
Total Receivables, Net 42.61 47.66 62.47 41.61
Accounts Receivables - Trade, Net 42.61 47.66 62.47 41.61
Total Inventory 38.6 37.69 42.71 18.82
Prepaid Expenses 10.22 11.97 2.61 2.95
Other Current Assets, Total 0.297 0.299 0.281 -
Total Assets 281.96 286.42 380.03 405.18
Property/Plant/Equipment, Total - Net 1.94 2.04 2.61 2.21
Property/Plant/Equipment, Total - Gross 6.64 6.67 7.11 6.53
Accumulated Depreciation, Total -4.7 -4.63 -4.5 -4.32
Goodwill, Net - - 19.86 -
Intangibles, Net 105.7 111.33 170.41 185.43
Long Term Investments - - - -
Note Receivable - Long Term - - - -
Other Long Term Assets, Total 1.85 1.99 2.19 2.41
Other Assets, Total -3.71 -9.68 -19.48 58.8
Total Current Liabilities 92.44 93.44 114.29 79.48
Accounts Payable 15.65 13.44 19 11.18
Payable/Accrued - - - -
Accrued Expenses 69.9 71.97 75.72 53.14
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.797 0.928 0.97 0.229
Other Current liabilities, Total 6.09 7.1 18.6 14.93
Total Liabilities 147.47 148.42 187.16 150.91
Total Long Term Debt 38.62 38.51 38.87 38.25
Long Term Debt 38.62 38.51 38.87 38.25
Capital Lease Obligations - - - -
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 16.41 16.46 34 33.18
Total Equity 134.49 138 192.87 254.27
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 0.009 0.009 0.009 0.005
Additional Paid-In Capital 790.54 789.54 787.02 568.88
Retained Earnings (Accumulated Deficit) -656.05 -651.54 -594.16 -314.62
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total - - - -
Total Liabilities & Shareholders' Equity 281.96 286.42 380.03 405.18
Total Common Shares Outstanding 95.12 94.67 94.55 56.51
Total Preferred Shares Outstanding - - - -
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ASRT Price Commentary

Write your thoughts about Assertio Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Сергей Полищук
Сергей Полищук Aug 03, 2023 22:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Whats going on?
Paul Wadwell
Paul Wadwell Mar 08, 2023 23:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Q4 2022 beats all analysts expectations. This will have them re-evaluating their target prices.
Kelly Myers
Kelly Myers Dec 17, 2021 15:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock will shine very bright next year IMO. GLA
Nomi London
Nomi London Dec 17, 2021 15:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why wahts the news ???
Jim Hansen
Jim Hansen Dec 17, 2021 15:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
very undervalued compared to its competitive set and is beating its own sales forecats
Kelly Myers
Kelly Myers Dec 17, 2021 15:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wrote this in dec 2021 when the price was less than $2. Very good investment :-) ive been riding the free shares wave for a while now after taking my initial investment out.
Edwin Foo
Edwin Foo Jul 21, 2021 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
dead stock.
Ekpo bassey
Ekpo bassey Mar 16, 2021 6:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is a very stupid stock
Billionaire Dreams
Billionaire Dreams Mar 16, 2021 6:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pls Elaborate On How A Stock Can Be Stupid? Do You Mean The Venuture?
KJ KJ
KJ KJ Mar 01, 2021 19:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
heading up after market
William Cocodia
William Cocodia Mar 01, 2021 19:23
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any movement with this?
arif shake
arif shake Dec 19, 2020 7:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This company will hit £$2.00 dollars by February
João Esteves
João Esteves Dec 19, 2020 7:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why you say that, mate?Based in which info? Thanks.
Chanie Taggart
Chanie Taggart Dec 19, 2020 7:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
In due time till Everyone gets talking about it.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email